LINDSAY MARTINEZ: Open Payments
NPI 1508410622 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 36 payments from 16 companies in 2025. Trend: 2023 $1,478 · 2024 $945 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $223 |
| PFIZER INC. | 3 | $47 |
| Lilly USA, LLC | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Gilead Sciences, Inc. | 2 | $35 |
| Krystal Biotech Inc | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Botanix SB Inc | 1 | $20 |
| Grifols USA, LLC | 1 | $20 |
Products named: VRAYLAR, QULIPTA, JARDIANCE, NURTEC ODT, VYJUVEK, MOUNJARO, AIRSUPRA, CAPLYTA.
Industry payments across UT — which companies pay providers there.
